ES2572502T3 - Dispositivos de recogida de sangre que contienen un agente de estabilización de la sangre - Google Patents

Dispositivos de recogida de sangre que contienen un agente de estabilización de la sangre

Info

Publication number
ES2572502T3
ES2572502T3 ES11844851T ES11844851T ES2572502T3 ES 2572502 T3 ES2572502 T3 ES 2572502T3 ES 11844851 T ES11844851 T ES 11844851T ES 11844851 T ES11844851 T ES 11844851T ES 2572502 T3 ES2572502 T3 ES 2572502T3
Authority
ES
Spain
Prior art keywords
blood
variegina
seq
collection devices
devices containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11844851T
Other languages
English (en)
Inventor
Craig Gelfand
Daniel Marchiarullo
Keith Moskowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Application granted granted Critical
Publication of ES2572502T3 publication Critical patent/ES2572502T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
    • A61B5/154—Devices using pre-evacuated means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/15003—Source of blood for venous or arterial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150251—Collection chamber divided into at least two compartments, e.g. for division of samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150305—Packages specially adapted for piercing devices or blood sampling devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150351—Caps, stoppers or lids for sealing or closing a blood collection vessel or container, e.g. a test-tube or syringe barrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082—Test tubes per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un dispositivo para recoger y estabilizar sangre o un componente de la misma, donde el dispositivo tiene un primer extremo y un segundo extremo y al menos una pared interior que define una parte de depósito para recibir sangre, en el que el depósito contiene un agente de estabilización de la sangre que comprende a) variegina que tiene la secuencia de aminoácidos designada SEQ ID NO: 1, o un análogo de la misma tal como el análogo de variegina que es un fragmento de la SEQ ID NO: 1 y que se selecciona de las SEQ ID NO: 2-5, o el análogo de variegina que se designa SEQ ID NO: 6; o b) un disacárido polisulfatado, preferentemente octasulfato de sacarosa, o una combinación de los mismos, cada uno en una cantidad eficaz para estabilizar la sangre o un componente de la misma, en el que la variegina designada SEQ ID NO: 1 o el análogo de la misma pueden estar presentes en el dispositivo en una concentración de aproximadamente 1 μM a aproximadamente 1 mM, y en el que el disacárido polisulfatado puede estar presente en el dispositivo en una concentración de aproximadamente 50 μM a aproximadamente 50 mM.
ES11844851T 2010-12-02 2011-12-02 Dispositivos de recogida de sangre que contienen un agente de estabilización de la sangre Active ES2572502T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41906310P 2010-12-02 2010-12-02
PCT/US2011/063086 WO2012075407A2 (en) 2010-12-02 2011-12-02 Blood collection devices containing blood stabilization agent

Publications (1)

Publication Number Publication Date
ES2572502T3 true ES2572502T3 (es) 2016-05-31

Family

ID=46172595

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11844851T Active ES2572502T3 (es) 2010-12-02 2011-12-02 Dispositivos de recogida de sangre que contienen un agente de estabilización de la sangre

Country Status (10)

Country Link
US (1) US10299714B2 (es)
EP (1) EP2645932B1 (es)
JP (1) JP5937612B2 (es)
CN (1) CN103384496B (es)
AU (1) AU2011336345B2 (es)
BR (1) BR112013013414B1 (es)
CA (1) CA2818522C (es)
ES (1) ES2572502T3 (es)
MX (1) MX346717B (es)
WO (1) WO2012075407A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
CA2897336C (en) 2013-01-20 2023-10-17 Dyax Corp. Evaluation and treatment of pkal-mediated disorders
CN105188535A (zh) * 2013-02-01 2015-12-23 贝克顿·迪金森公司 含有接触途径抑制添加剂的血液采集装置
PL3060582T3 (pl) 2013-10-21 2021-05-04 Dyax Corp. Testy do oznaczania biomarkerów układu kalikreiny osoczowej
EP3154338B1 (en) * 2014-06-10 2020-01-29 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
CN104068867A (zh) * 2014-06-27 2014-10-01 安徽信灵检验医学科技有限公司 一种真空采血系统及其使用方法
EP3099235B8 (en) 2014-07-02 2017-11-29 Site Saver, Inc. Venous access device
CN104634628B (zh) * 2014-12-16 2017-03-29 广东腾飞基因科技有限公司 一种血液稳定剂及其应用
KR102555147B1 (ko) * 2015-01-22 2023-07-13 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 혈소판 풍부 혈장 및 골수 흡인물 세포 분리 및 제거 방법과 장치
JP6903648B2 (ja) * 2015-10-19 2021-07-14 ダイアックス コーポレーション 切断高分子量キニノーゲンを検出するイムノアッセイ
EA038186B1 (ru) * 2015-11-03 2021-07-21 Хелс Корпорейшн Оф Галилея Медикал Сентр Устройство и способ для обработки искусственного костного имплантата кровью
CN108700498B (zh) 2015-12-08 2021-07-13 生物马特里卡公司 降低红细胞沉降速率
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂
CN106913348B (zh) * 2017-03-31 2023-06-23 汪学耀 一种预稀释真空采血管及测量血小板数目的方法
CN107201307B (zh) * 2017-05-27 2019-09-13 广州基赛生物科技有限公司 一种采血管及其应用
CN107727587B (zh) * 2017-09-22 2020-06-19 宁波瑞源生物科技有限公司 一种抗凝血酶ⅲ测定试剂盒及其检测方法
CN107569244A (zh) * 2017-10-16 2018-01-12 李玉斌 一种血管外科用采血管
EP3710806A1 (en) * 2017-11-15 2020-09-23 Radiometer Medical ApS Heparin-based blood sampler without platelet activation
DE102018218739B3 (de) * 2018-11-01 2020-03-19 Sarstedt Ag & Co. Kg Blutentnahmeröhre und Verfahren zur Präparation
US20210113127A1 (en) * 2019-10-16 2021-04-22 Becton, Dickinson And Company Multi-chamber blood collection device and related systems and methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB711779A (en) * 1950-07-07 1954-07-14 Nat Res Dev Improvements in or relating to electronic information storage systems and discharge tubes therefor
JPS6053845A (ja) * 1983-09-05 1985-03-27 Terumo Corp 血液分離管
NZ236033A (en) * 1989-11-13 1994-11-25 Davol Inc Blood pump: filtering with tangential flow separation
WO1993003748A1 (en) 1991-08-13 1993-03-04 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
JPH06192291A (ja) * 1992-09-07 1994-07-12 Nippon Steel Corp 新規ペプチドとそれを用いた血小板凝集抑制剤及び血液凝固抑制剤
JP2723473B2 (ja) * 1994-09-22 1998-03-09 ブーク メデイテツク エイ／エス 硫酸化糖類の用途
AU703256B2 (en) 1995-06-09 1999-03-25 Regents Of The University Of Michigan, The Bradykinin analogs as selective thrombin inhibitors
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
IL132546A0 (en) 1997-04-23 2001-03-19 Univ Michigan Bradykinin analogs as selective inhibitors of cell activation
US6544750B1 (en) 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
AUPR612801A0 (en) * 2001-07-04 2001-07-26 Australian National University, The Linked cyclitols and their polysulfated derivatives
CN100389880C (zh) * 2002-05-07 2008-05-28 贝克顿·迪金森公司 采集组件
BR0309976A (pt) 2002-05-13 2005-03-01 Becton Dickinson Co Sistema de coleta de amostra inibidor de protease
EP1413874A1 (en) 2002-10-16 2004-04-28 Streck Laboratories, Inc. Method and device for collecting and preserving cells for analysis
US7074765B2 (en) 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US20090123907A1 (en) * 2004-07-22 2009-05-14 Shanbrom Technologies, Llc Lysine citrate for plasma protein and donor protection
JP2006288680A (ja) * 2005-04-11 2006-10-26 Enomoto Co Ltd 採血キット
US7879792B2 (en) 2005-06-02 2011-02-01 The Regents Of The University Of Michigan Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
JP2008185564A (ja) * 2007-01-31 2008-08-14 Fujimori Kogyo Co Ltd 血液凝固能の検査方法および血液凝固能の検査装置
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
WO2009017689A2 (en) * 2007-08-02 2009-02-05 Government Of The U. S. A., As Represented By The Secretary, Dept. Of Health And Human Services Methods for detection and prevention of tick infestation and pathogen transmission
KR101923152B1 (ko) * 2007-12-04 2018-11-28 프로테오바이오엑티브스 피티와이 엘티디 전구 세포의 보호 및 그의 분화 조절
GB0907698D0 (en) * 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors

Also Published As

Publication number Publication date
WO2012075407A2 (en) 2012-06-07
CA2818522A1 (en) 2012-06-07
CN103384496B (zh) 2016-10-12
EP2645932A4 (en) 2014-06-04
MX346717B (es) 2017-03-29
EP2645932A2 (en) 2013-10-09
JP5937612B2 (ja) 2016-06-22
CN103384496A (zh) 2013-11-06
JP2014506319A (ja) 2014-03-13
WO2012075407A3 (en) 2012-10-04
BR112013013414B1 (pt) 2023-01-10
AU2011336345B2 (en) 2016-07-07
US10299714B2 (en) 2019-05-28
AU2011336345A1 (en) 2013-06-20
EP2645932B1 (en) 2016-03-02
US20120149004A1 (en) 2012-06-14
CA2818522C (en) 2016-05-17
MX2013006073A (es) 2013-07-15
BR112013013414A2 (pt) 2016-09-13

Similar Documents

Publication Publication Date Title
ES2572502T3 (es) Dispositivos de recogida de sangre que contienen un agente de estabilización de la sangre
BR112016016290A2 (pt) Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina
NI201200013A (es) Composición de insulina de acción prolongada
CL2013002517A1 (es) Compuestos derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina; procedimiento de preparacion; composicion farmaceutica que los comprende; su uso en el tratamiento o profilaxis del cancer.
BR112015018904A2 (pt) limpador de desinfecção de orifício de acesso e conector sem agulha e cobertura de proteção antimicrobiana
PE20130649A1 (es) Moleculas polinucleotidicas para regulacion genetica en plantas
ECSP11011478A (es) Marcadores de eventos ingeribles altamente confiables y métodos para usarlos
WO2016090359A3 (en) Glass composites for tissue augmentation, biomedical and cosmetic applications
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
UY32327A (es) Antagonistas de receptores de ácido lisofosfatídico
BR112018069251A2 (pt) métodos de intervenção precoce para prevenir ou melhorar a toxicidade
BR112015000161A2 (pt) composições de vetor de vírus adeno-associado modificado
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
BR112015004704A2 (pt) sistema de preensão, dispositivo de preensão configurado para prender um artigo médico que tem um corpo alongado, retentor, e dispositivo de preensão configurado para prender um artigo médico que tem um corpo alongado a um paciente
BR112015012161A8 (pt) agente de crioproteção e seu uso, composições de crioproteção e método para criopreservar amostra".
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
BR112015001898A2 (pt) sistema para identificar artefatos de movimentação; e método para identificar artefatos de movimentação
BRPI0904882B8 (pt) dispositivo de acesso cirúrgico
EA201200519A1 (ru) Стабилизированные жидкие и лиофилизированные композиции adamts13
CU20100032A7 (es) Depsipéptidos cíclicos
EA201591152A1 (ru) Аморфный карбонат кальция для ускоренного роста костной ткани
AR078736A1 (es) Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion
BR112015030355A8 (pt) uso de uma proteína ou um polipeptídeo de adenilil ciclase tipo 6 (ac6) incompetente com a adenosina monofosfato cíclico (incompetente com camp) ou um gene ou ácido nucléico que codifica ac6mut, e, formulação
MX2020004811A (es) Métodos y composiciones de reconstrucción no mieloablativa de médula ósea.
AR101814A1 (es) Partícula de tipo virus flavivirus